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ABSTRACT
Background: The urachus is a vestigial structure between
the dome of the bladder and the umbilicus. Tumors may
develop from the remnants, most of which are well-dif-
ferentiated, mucinous adenocarcinomas. Urachal adeno-
carcinoma is an exceedingly rare type of tumor.
Methods: We present a case of a 51-year-old female
presenting to our institution with complaints of abdominal
pain for 36 hours. The patient was taken to the operating
room for an acute appendicitis. Laparoscopy was per-
formed, and gross purulence and appendiceal perforation
were noted as well as a mass on the anterior abdominal
wall. Based on the location of the mass, we converted to
an open midline laparotomy to treat both the perforated
appendicitis and to remove the mass.
Results: Pathology confirmed the diagnosis of perforated
appendicitis and a mucinous-producing urachal adeno-
carcinoma.
Discussion: Data support both open and laparoscopic
approaches for appendicitis. This case, although rare,
highlights the importance of laparoscopy in a complete
and thorough examination of the abdominal cavity. A
standard right lower quadrant incision for an open tech-
nique would likely have resulted in omission of this le-
sion, and the patient would have presented at a more
typical late stage of her cancer development with signifi-
cantly more morbidity.
Key Words: Urachal adenocarcinoma, Ruptured appen-
dicitis, Laparoscopy.
INTRODUCTION
The urachus is a vestigial structure between the dome of
the bladder and the umbilicus. It represents the apical
attachment of the bladder to the allantois during human
fetal development.1 It usually retracts from the bladder
before birth, but its lumen, which is lined by transitional
or columnar epithelium, may persist within the bladder
wall and be continuous with the bladder cavity even in
adults. Tumors may develop from the remnants, most of
which are well-differentiated mucinous adenocarcino-
mas.2 Urachal adenocarcinoma is an exceedingly rare type
of tumor. These tumors account for less than 1% of all
bladder tumors.3–8
CASE REPORT
We present the case of a 51-year-old white female who
presented to our institution with complaints of abdominal
pain for approximately 36 hours. The pain was described
in her history as more localized to the epigastrium, but she
was more tender in the right lower quadrant. She de-
scribed this pain as achy and constant with positive nau-
sea and emesis. She noted a decreased appetite and diar-
rhea for approximately 1 week. She denied any fever or
chills at home over that time. She also described a strain-
ing sensation on urination but no associated dysuria or
blood. All other system reviews were noncontributory.
The patient denied any significant past medical, social, or
family history.
On physical examination, her temperature was 101.2°
with other vital signs being stable. Her abdominal exam-
ination indicated that the abdomen was quiescent, soft,
hot to the touch, and nondistended. McBurney’s sign,
Rovsing’s sign, Merkel’s sign, and rebound throughout
were positive. The only significant laboratory value was
an elevated white blood cell count of 15.8x10
9. A CT scan
ordered in the emergency department was interpreted as
showing the presence of fluid in the RLQ with pericecal
haziness and fluid in the paracolic gutter. Fluid was noted
in the pelvis as well as a left ovarian cyst approximately
2.5 cm in size. Another cyst was identified in the right lobe
of the liver approximately 1.5 cm in size (Figure 1).
The decision was made to perform a laparoscopic appen-
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CASE REPORTdectomy. The patient was taken to the operating room
where a diagnostic laparoscopy was performed. On entry
into the abdomen, gross purulence was noted in the pelvis
(Figure 2) and subhepatic space. A mass was found on
the anterior abdominal wall in the midline to which the
omentum was adherent (Figure 3). Once the inflamma-
tory mass was moved laterally, we noted a perforated
appendix and the anterior abdominal wall mass was
clearly a separate entity (Figures 4 and 5). At this point,
we converted to an open midline laparotomy so as to
clearly remove the midline mass. After performing our
standard open appendectomy, we turned our attention to
the midline mass. We were able to dissect it free with
grossly clear margins, but on the inferior surface were
obligated to remove a small portion of the bladder. Post-
operatively, the pathology of the mass came back as a
primary urachal adenocarcinoma. The patient did well
postoperatively, and a positron emission tomographic
(PET) scan done 6 weeks postoperatively was negative for
any further evidence of tumor spread. A colonoscopy
done at that time also was completely normal. The patient
did not follow up with her medical oncologist until 6
months later at which time she underwent a computed
tomographic (CT) scan of the chest, abdomen, and pelvis.
No evidence of recurrent disease was present. Because of
the length of time after surgery and her follow-up with
Figure 1. Computed tomographic scan showing pericecal fluid
consistent with acute appendicitis.
Figure 2. Purulent drainage in pelvis.
Figure 3. Gross appearance of anterior abdominal wall mass
with adherent appendix.
Figure 4. Perforated appendix.
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therapy.
RESULTS
The specimen consisted of a 33-gram circumscribed,
bosselated red-tan mass, measuring 5.0 x4.5x3.8 cm. A cut
section revealed multiple locules filled with a viscid, pale
gelatinous fluid. Microscopic sections revealed a muci-
nous neoplasm arising external to the muscularis propria
of the bladder. The urothelium showed reactive features but
was not directly involved by the mass. High-power exami-
nation revealed that the mucinous pools were lined by a
columnar epithelium with malignant features (Figure 6).
The accompanying appendix was completely examined
and showed acute appendicitis. No evidence was present
of a mucinous neoplasm within the appendix. Clinical and
radiographic evaluation of the ovaries and gastrointestinal
tract revealed no evidence of a neoplasm. The lack of
involvement by ovaries, appendix, and other gastrointes-
tinal organs served to rule out a metastatic lesion from
those locations. Accordingly, the bladder mass was diag-
nosed as a mucin-producing adenocarcinoma, consistent
with urachal adenocarcinoma.
DISCUSSION
Primary urachal adenocarcinoma is exceedingly rare ac-
counting for less than 1% of all bladder malignancies.
Urachal adenocarcinoma is more common in men and
typically presents in the fifth or sixth decade of life.9
Common presenting symptoms are hematuria, pain, irri-
tative symptoms, and mucosuria. Late findings include
mucinous or serous drainage from a tract in the umbilicus.
Histologically, these tumors are most commonly the mu-
cinous type.10 Currently, no absolute consensus exists
regarding diagnostic criteria. Several authors agree that
the important clinicopathologic features of a primary ura-
chal adenocarcinoma include1 location of the tumor in the
bladder wall,2 evidence of a sharp demarcation between
the tumor and surface epithelium,3 exclusion of a primary
tumor located elsewhere that has spread to the bladder,
and4 a urachal remnant associated with the tumor.11–13
Because of the typical late presentation of these tumors,
the prognosis is poor. The 5-year survival rate reported by
several authors is between 16% and 45%.14,15 Complete
resection improves overall survival as does early diagnosis
and surgical intervention. The role for chemotherapy in
urachal adenocarcinoma is not well established. The most
recent study addressing this issue from The University of
Texas M.D. Anderson Cancer Center advocates the use
of 5-flourouracil and cisplatin with either -interferon or
gemcitabine and leucovorin.16
CONCLUSION
It is our hope that with the early finding of the urachal
mass and complete resection that we have provided a
long-term cure. Our expectation is that this case report
will add to the body of literature supporting a laparo-
scopic approach to evaluation of abdominal pathology.
We believe that had this patient been treated with a
standard open approach for appendicitis on initial explo-
ration, the urachal mass would not have been found.
Furthermore, diagnostic laparoscopy allowed us to fully
Figure 5. Anterior wall abdominal mass.
Figure 6. High-power view of specimen revealing pools of
mucin.
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appropriate surgical incision without compromising the
integrity of the mass, allowing us to remove it in its
entirety. Currently, this patient remains disease free after
12 months of follow-up.
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